Literature DB >> 30386604

Cancer risk perception in relation to associated symptoms in Barrett's patients: A cross sectional study on quality of life.

Mirjam Cm van der Ende-van Loon1, Wilda D Rosmolen2, Saskia Houterman3, Erik J Schoon1, Wouter L Curvers1.   

Abstract

BACKGROUND: Barrett's oesophagus affects patients' quality of life and may be a psychological burden due to the threat of developing an oesophageal adenocarcinoma.
OBJECTIVE: Assessing the oesophageal adenocarcinoma risk perceived by non-dysplastic Barrett's oesophagus patients and its association with quality of life, illness perception and reflux symptoms.
METHODS: This cross-sectional questionnaire study included 158 Barrett's oesophagus non-dysplastic patients aged 18-75 years. Based on their annual and lifetime oesophageal adenocarcinoma risk estimations measured with the Magnifier Scale, patients were classified as overestimating or underestimating. Associations between the groups where assed on demographics, reflux symptoms and results of the Outcomes Study Short-Form-36 (SF-36) and the Brief Illness Perception Questionnaire (B-IPQ).
RESULTS: The annual oesophageal adenocarcinoma risk was overestimated by 41%. Overestimating patients had lower means on the SF-36 domains: bodily pain (annual p = 0.007 and lifetime p = 0.014), general health (annual p = 0.011 and lifetime p = 0.014), vitality (annual p = 0.030), physical functioning (lifetime p = 0.028), worse illness perception (total score p = 0.001) and significantly more reflux symptoms.
CONCLUSIONS: Overestimation of the oesophageal adenocarcinoma risk by Barrett's oesophagus patients was associated with decreased quality of life and worse illness perceptions, which is most likely caused by symptoms of dyspepsia and reflux. These symptoms should be adequately treated, and patients may be in need of extra support and specific information about their oesophageal adenocarcinoma risk.

Entities:  

Keywords:  Barrett’s oesophagus; functional dyspepsia; perceived cancer risk; quality of life; reflux

Year:  2018        PMID: 30386604      PMCID: PMC6206536          DOI: 10.1177/2050640618798508

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  19 in total

1.  Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.

Authors:  M A Eloubeidi; D Provenzale
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

2.  The brief illness perception questionnaire.

Authors:  Elizabeth Broadbent; Keith J Petrie; Jodie Main; John Weinman
Journal:  J Psychosom Res       Date:  2006-06       Impact factor: 3.006

3.  Illness perceptions: a new paradigm for psychosomatics?

Authors:  J Weinman; K J Petrie
Journal:  J Psychosom Res       Date:  1997-02       Impact factor: 3.006

4.  A new scale for assessing perceptions of chance: a validation study.

Authors:  S Woloshin; L M Schwartz; S Byram; B Fischhoff; H G Welch
Journal:  Med Decis Making       Date:  2000 Jul-Sep       Impact factor: 2.583

5.  Association of Smoking in the Home With Lung Cancer Worry, Perceived Risk, and Synergistic Risk.

Authors:  Karen M Butler; Mary Kay Rayens; Amanda T Wiggins; Kathy B Rademacher; Ellen J Hahn
Journal:  Oncol Nurs Forum       Date:  2017-03-01       Impact factor: 2.172

6.  Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease.

Authors:  C Jonasson; B Wernersson; D A L Hoff; J G Hatlebakk
Journal:  Aliment Pharmacol Ther       Date:  2013-01-07       Impact factor: 8.171

7.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

8.  Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care.

Authors:  R Jones; O Junghard; J Dent; N Vakil; K Halling; B Wernersson; T Lind
Journal:  Aliment Pharmacol Ther       Date:  2009-09-08       Impact factor: 8.171

9.  Distress among inflammatory bowel disease patients at high risk for colorectal cancer: a preliminary investigation of the effects of family history of cancer, disease duration, and perceived social support.

Authors:  Christine Rini; Lina Jandorf; Heiddis Valdimarsdottir; Karen Brown; Steven H Itzkowitz
Journal:  Psychooncology       Date:  2008-04       Impact factor: 3.894

10.  Health-related quality of life of subjects with Barrett's esophagus in a Chinese population.

Authors:  Shou-Wu Lee; Han-Chung Lien; Chi-Sen Chang; Chung-Wang Ko; Chun-Fang Tung; Hong-Zen Yeh
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

View more
  4 in total

1.  Systematic review with meta-analysis: age-related malignancy detection rates at upper gastrointestinal endoscopy.

Authors:  Judith J de Jong; Marten A Lantinga; Ina M E Thijs; Philip R de Reuver; Joost P H Drenth
Journal:  Therap Adv Gastroenterol       Date:  2020-11-04       Impact factor: 4.409

Review 2.  Insights Into the Oral Microbiome and Barrett's Esophagus Early Detection: A Narrative Review.

Authors:  Zhenzhen Zhang; Grace Curran; Duygu Altinok Dindar; Ying Wu; Hui Wu; Thomas Sharpton; Lianmei Zhao; David Lieberman; Fouad Otaki
Journal:  Clin Transl Gastroenterol       Date:  2021-08-26       Impact factor: 4.488

Review 3.  How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurements.

Authors:  Mirjam C M van der Ende-van Loon; A Stoker; P T Nieuwkerk; W L Curvers; E J Schoon
Journal:  Qual Life Res       Date:  2021-11-08       Impact factor: 3.440

4.  Barrett Esophagus: Quality of life and factors associated with illness perception.

Authors:  Mirjam C M van der Ende-van Loon; Pythia T Nieuwkerk; Stephan H C van Stiphout; Robert C H Scheffer; Rogier J J de Ridder; Roos E Pouw; Alaa Alkhalaf; Bas L A M Weusten; Wouter L Curvers; Erik J Schoon
Journal:  United European Gastroenterol J       Date:  2022-07-06       Impact factor: 6.866

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.